CPR Invest - Defensive - I EUR - Acc ISIN : LU1203018707
CPR Invest - Defensive - I EUR - Acc
I(C) - LU1203018707
Asset class: Balanced
YTD
As of 17/11/2026-3.34%
Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.
NAV
As of 18/11/2026€105,602.50
SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8
Fund AUM
As of 18/11/2026€18.14M
A global balanced fund whose objective is to outperform the benchmark over a 2-year min. investment horizon while delivering a maximum ex-ante volatility of 7%. The fund's equity exposure ranges from 0% to 30%. Exposure to risk carrying assets, as defined in the fund's prospectus, is limited to 40% maximum. The modified duration on the fixed income section ranges between -2 and +8. CPR INVEST - Defensive is a feeder fund of French-domiciled FCP, CPR Croissance Defensive.
NAVs
NAV from 21/11/2016 to 18/11/2026
Select period
Performance
Change in NAV in base 100
FundCPR Invest - Defensive - I EUR - Acc (7.12% over the period)
Select period
B. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
Change in NAV in base 100Rolling performancesYear-on-year return (365 days)Annual returnsRisk indicatorsPerformances Scenarios
FundCPR Invest - Defensive - I EUR - Acc (7.12% over the period)
Select period
B. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
Portfolio Analysis
Repartition 10/31/2026
Main Lines in Portfolio (Source: Amundi)Geographical breakdown (Source: Amundi)Geographical breakdown (Source: Amundi)CurrencyPortfolio Breakdown by Maturity (Source: Amundi)
Sector | Weight | |
|---|---|---|
| ARI - EUROPEAN CREDIT- I2 - C | Investment Grade EMU | 14.39% |
| CPR INVEST - CLIMATE BONDS EURO - Z EUR | Investment Grade EMU | 13.27% |
| BFT AUREUS ISR - Z (C) | Money Market Investments | 10.72% |
| CPR ABSOLUTE RETURN BONDS - Z (C) | Absolute Return Fixed Income | 10.09% |
| abrdn Em Mkt Lcl Ccy Dbt K Acc EUR | Govies Emerging Global | 9.84% |
| Amundi EUR Corporate Bond ESG ETF DR C | Investment Grade EMU | 9.51% |
| Amundi EUR Corporate Bond 1-5Y ESG ETF A | Investment Grade EMU | 7.43% |
| CPR INV B&W EU STRAT AUTO 2028 II | Investment Grade Europe | 5.24% |
| Amundi MSCI World Swap II ETF Acc | Equities World | 5.04% |
| AMUN EUR HY Corp Bd ESG UCITS Dist (PAR) | High Yield Europe | 2.32% |
Management commentary
Effective date: 31/10/2026
The month of October 2026 was marked by a new surge in energy prices. Indeed, attacks on ships continued in the Strait of Hormuz, the Houthis claimed responsibility for strikes on several Saudi refineries, and Donald Trump hinted that US strikes on Iran could resume after the midterm elections on November 3. As a result, the price of Brent crude rose by nearly 14% over the month, reaching $118, its highest level in six months. The price of natural gas also increased sharply, reaching its highest level since the end of 2022. Another key event of the month was the sharp decline in technology stocks at the very end of the month, following disappointing earnings reports from Alphabet, Amazon, and Intel, which reignited doubts about the profitability of massive investments in AI.
The inflation indices published in October, covering the month of September, accelerated again due to energy prices. In the eurozone, headline inflation reached 3.8% compared to 3.2% in August, its highest level since September 2023, with the energy component rising by 18.8% year-on-year. In contrast, core inflation remained broadly stable at 2.5%. In the United States, headline inflation (CPI) rose from 3.4% to 3.7%, while core inflation climbed to 2.6%, slightly higher than expected. The September “core PCE” inflation came in at 3.1%.
Activity indicators continued to be solid. In the United States, Q3 GDP growth came in at 3.4% quarter-on-quarter annualized, above expectations, driven by consumption and business investment. However, after a strong report in August, the September employment report disappointed, with only 29,000 non-farm jobs created and an increase in the unemployment rate to 4.2%. In the eurozone, GDP grew by 0.4% in Q3, despite a surprise contraction of 0.1% in France, but the composite PMI fell to 51.9 in October from 53.1 in September, well below expectations. In China, GDP growth came in at 4.5% year-on-year in Q3, but the economy remains highly unbalanced and household consumption very weak.
After September, the first month in history during which the ECB, the Fed, and the BoJ all raised their key rates, these three central banks all decided to leave their rates unchanged in October. The Fed maintained the fed funds target range at 3.75/4%, but two FOMC members (Lisa Cook and Beth Hammack) voted in favor of another hike. Kevin Warsh indicated that the September rate hike had begun to take effect and that the tightening of financial conditions was paving the way for a more sustainable period of growth and price stability. For its part, the BoJ left its main policy rate at 1.25% but opened the door to a hike in December. Finally, the ECB left its deposit rate at 2.50%, even though energy prices in Europe are now between the “adverse” and “severe” scenarios mentioned in September, fueling upside risks for inflation and downside risks for growth. The Council debated a new rate hike but judged that uncertainties were still too high, while indicating that “the direction is quite clear” for all its members. For now, it does not see a substantial risk of second-round effects.
Despite the rise in oil prices, bond yields fell sharply over the month, benefiting from a flight to safe-haven assets at the end of the month and the central banks’ pause. The US 10-year yield fell by nearly 40 bps to 4.90%, after briefly exceeding 5.30% during the month. The German 10-year yield fell by about 25 bps over the month to 3.29%, returning to its end-August levels. In Japan, the 10-year yield fell back below the 3% mark, to 2.77%, its lowest level in nearly three months. Finally, gold fell again, by about 6% over the month, to just over $3,875 an ounce, penalized by the prospect of further Fed rate hikes.
Equity markets were shaken at the end of the month by doubts about the profitability of AI-related investments. The S&P 500 fell by 0.9% over the month and the Nasdaq by more than 5%, while the Dow Jones rose by 1.7%. The Eurostoxx 600 was more resilient, rising by 1.9%. Asian markets, more exposed to the semiconductor sector, fell sharply: the Nikkei lost nearly 5.2% and the MSCI Emerging dropped 8.1%, its worst month since the start of the war in Iran.
Within the Growth range, allocations favored broad indices and the US health care and energy sectors. Positions on the Nasdaq 100 and several thematic technology and emerging exposures were reduced.
CPR Croissance Défensive. The P share fell by 1.01%, compared to a 0.20% increase in the capitalized €STR. Euro investment grade credit was the main support in the face of the decline in technology and emerging exposures. Net equity exposure increased by 2.72 points to 22.00%, with a strengthening of North American equities (health care and energy sectors) and a reduction in emerging equities. Rate sensitivity rose from 2.62 to 2.95 points.
We approach November with a slightly cautious equity bias, an underweight in the US focused on technology, and a slight preference for health care and energy. On rates, we favor contained sensitivity and maturities of five to seven years. US high yield remains a selective source of carry, while quality euro credit remains preferred.
The inflation indices published in October, covering the month of September, accelerated again due to energy prices. In the eurozone, headline inflation reached 3.8% compared to 3.2% in August, its highest level since September 2023, with the energy component rising by 18.8% year-on-year. In contrast, core inflation remained broadly stable at 2.5%. In the United States, headline inflation (CPI) rose from 3.4% to 3.7%, while core inflation climbed to 2.6%, slightly higher than expected. The September “core PCE” inflation came in at 3.1%.
Activity indicators continued to be solid. In the United States, Q3 GDP growth came in at 3.4% quarter-on-quarter annualized, above expectations, driven by consumption and business investment. However, after a strong report in August, the September employment report disappointed, with only 29,000 non-farm jobs created and an increase in the unemployment rate to 4.2%. In the eurozone, GDP grew by 0.4% in Q3, despite a surprise contraction of 0.1% in France, but the composite PMI fell to 51.9 in October from 53.1 in September, well below expectations. In China, GDP growth came in at 4.5% year-on-year in Q3, but the economy remains highly unbalanced and household consumption very weak.
After September, the first month in history during which the ECB, the Fed, and the BoJ all raised their key rates, these three central banks all decided to leave their rates unchanged in October. The Fed maintained the fed funds target range at 3.75/4%, but two FOMC members (Lisa Cook and Beth Hammack) voted in favor of another hike. Kevin Warsh indicated that the September rate hike had begun to take effect and that the tightening of financial conditions was paving the way for a more sustainable period of growth and price stability. For its part, the BoJ left its main policy rate at 1.25% but opened the door to a hike in December. Finally, the ECB left its deposit rate at 2.50%, even though energy prices in Europe are now between the “adverse” and “severe” scenarios mentioned in September, fueling upside risks for inflation and downside risks for growth. The Council debated a new rate hike but judged that uncertainties were still too high, while indicating that “the direction is quite clear” for all its members. For now, it does not see a substantial risk of second-round effects.
Despite the rise in oil prices, bond yields fell sharply over the month, benefiting from a flight to safe-haven assets at the end of the month and the central banks’ pause. The US 10-year yield fell by nearly 40 bps to 4.90%, after briefly exceeding 5.30% during the month. The German 10-year yield fell by about 25 bps over the month to 3.29%, returning to its end-August levels. In Japan, the 10-year yield fell back below the 3% mark, to 2.77%, its lowest level in nearly three months. Finally, gold fell again, by about 6% over the month, to just over $3,875 an ounce, penalized by the prospect of further Fed rate hikes.
Equity markets were shaken at the end of the month by doubts about the profitability of AI-related investments. The S&P 500 fell by 0.9% over the month and the Nasdaq by more than 5%, while the Dow Jones rose by 1.7%. The Eurostoxx 600 was more resilient, rising by 1.9%. Asian markets, more exposed to the semiconductor sector, fell sharply: the Nikkei lost nearly 5.2% and the MSCI Emerging dropped 8.1%, its worst month since the start of the war in Iran.
Within the Growth range, allocations favored broad indices and the US health care and energy sectors. Positions on the Nasdaq 100 and several thematic technology and emerging exposures were reduced.
CPR Croissance Défensive. The P share fell by 1.01%, compared to a 0.20% increase in the capitalized €STR. Euro investment grade credit was the main support in the face of the decline in technology and emerging exposures. Net equity exposure increased by 2.72 points to 22.00%, with a strengthening of North American equities (health care and energy sectors) and a reduction in emerging equities. Rate sensitivity rose from 2.62 to 2.95 points.
We approach November with a slightly cautious equity bias, an underweight in the US focused on technology, and a slight preference for health care and energy. On rates, we favor contained sensitivity and maturities of five to seven years. US high yield remains a selective source of carry, while quality euro credit remains preferred.
Characteristics
General data
Inception date
27/03/2015First Nav Date
26/01/2011Currency
EURShow more
Valuation
DailyMinimum initial investment
100000 eurosMinimum additional investment
1 10/1000° share(s)/equityCosts Composition
| One-off costs upon entry or exit (Investment EUR 10,000) | If you exit after 1 year | ||
| Entry costs | This includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge. | Up to €500.00 | |
| Exit costs | We do not charge an exit fee for this product, but the person selling you the product may do so. | €0.00 | |
| Ongoing costs taken each year (Investment EUR 10,000) | |||
| Management fees and other administrative or operating costs | 1.14% of the value of your investment per year. This percentage is based on actual costs over the last year. | €108.02 | |
| Transaction costs | 0.00% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell. | €0.10 | |
| Incidental costs taken under specific conditions (Investment EUR 10,000) | |||
| Performance fees | 20.00% annual outperformance of the reference asset 100% ESTR CAPITALISE (OIS) + 1.5%. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years. The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset. | €0.00 | |
Codification
ISIN code
LU1203018707Bloomberg code
CPRDEIA LXReuters code
LP68308267Investment Objective
A global balanced fund whose objective is to outperform the benchmark over a 2-year min. investment horizon while delivering a maximum ex-ante volatility of 7%. The fund's equity exposure ranges from 0% to 30%. Exposure to risk carrying assets, as defined in the fund's prospectus, is limited to 40% maximum. The modified duration on the fixed income section ranges between -2 and +8. CPR INVEST - Defensive is a feeder fund of French-domiciled FCP, CPR Croissance Defensive.
Documents
| Language | Documents | Type | Closing Date |
|---|---|---|---|
SV | PDF | 14/09/2026 | |
EN | PDF | 31/07/2025 | |
PDF | 01/10/2026 | ||
PDF | 31/01/2026 | ||
SV | PDF | 31/10/2026 | |
EN | PDF | 26/10/2016 |
Sustainability-related disclosures
| Language | Documents | Type | Closing Date |
|---|---|---|---|
SV | PDF | 01/01/2025 | |
EN | PDF | 03/08/2026 |